Methamphetamine Use Disorder Clinical Trial
Official title:
Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder
We will evaluate the effects of deep brain stimulation (DBS) of bilateral nucleus accumbens (NAc) added to background treatment for treatment refractory Methamphetamine Use Disorder (MUD). This is a small randomized cross-over study to demonstrate feasibility and safety, test treatment outcomes (use, craving), and identify novel biological targets (NAc local field potentials (LFP) and functional MRI).
In a randomized cross-over design of DBS of the nucleus accumbens (NAc) for treatment refractory methamphetamine use disorder (MUD, n=5), we will test safety, feasibility, effect on clinical outcomes (craving and use), and seek to identify biological targets (using cue craving during recording of local field potentials and MRI). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04178993 -
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
|
Phase 1 | |
Completed |
NCT01982643 -
Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT03078075 -
Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder
|
Phase 3 | |
Terminated |
NCT05711862 -
The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder
|
Phase 2 | |
Recruiting |
NCT05322954 -
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
|
Phase 1 | |
Recruiting |
NCT05760807 -
Intranasal Oxytocin for Methamphetamine Withdrawal in Women
|
N/A | |
Recruiting |
NCT04614584 -
Mirtazapine and Methamphetamine Drug-drug Interaction Study
|
Phase 1 | |
Not yet recruiting |
NCT06320366 -
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
|
N/A | |
Active, not recruiting |
NCT06279273 -
A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment
|
N/A | |
Active, not recruiting |
NCT04907357 -
rTMS for Stimulant Use Disorders
|
N/A | |
Completed |
NCT04713124 -
A Telephone-delievered Intervention to Reduce Methamphetamine Use
|
N/A | |
Active, not recruiting |
NCT04791969 -
Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
|
Phase 2 | |
Completed |
NCT00572234 -
Bupropion in the Treatment of Methamphetamine Dependence
|
N/A | |
Terminated |
NCT03106571 -
Study of Pomaglumetad and Methamphetamine
|
Phase 1 | |
Recruiting |
NCT06033365 -
Beginning Early and Assertive Treatment for Methamphetamine Use Disorder
|
N/A |